GLP-1 Weight Loss and Body Contouring: Dr. Daniel Gould Featured in Allure

GLP-1 medications such as Ozempic, Wegovy, and Mounjaro are changing plastic surgery, especially in the area of body contouring and scar management.

As more patients experience rapid weight loss with GLP-1 medications, surgeons are seeing increased demand for procedures that address loose skin, tissue laxity, and contour changes in the face, breasts, arms, thighs, and abdomen. In the article, Dr. Gould explains that many GLP-1 patients are not massive weight-loss patients, but still develop noticeable skin laxity and volume loss that can benefit from tailored surgical planning.

The feature also explores how plastic surgeons are adapting body contouring techniques for this new patient population. Topics include smaller-scar lifts, wound-healing challenges, nutritional optimization before surgery, advanced suturing strategies, and post-operative scar treatments designed to improve recovery and results. Dr. Gould also discusses concerns around collagen quality, vitamin deficiencies, delayed healing, and wound dehiscence in some GLP-1 patients, emphasizing the importance of preparation and individualized care.

As GLP-1 medications continue to expand, this article highlights how body contouring surgery is evolving to meet the needs of patients seeking more refined results, better healing, and less visible scarring after weight loss.